Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parameters.

by Konstantin Schlick, Teresa Magnes, Lukas Ratzinger, Bernhard Jaud, Lukas Weiss, Thomas Melchardt, Richard Greil, Alexander Egle
Published 2018-01-01

Panitumumab-associated encephalopathy after accidental intra-arterial application through dislocated Port-a-Cath device in the left ventricle

by Slaven Pikija, Georg Pilz, Gerald Gschwandtner, Cornelia Rösler, Konstantin Schlick, Richard Greil, Johann Sellner, Johann Sellner
Published 2016-11-01

C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling overall survival Prediction in Pancreatic Cancer Patients

by Konstantin Schlick, Teresa Magnes, Florian Huemer, Lukas Ratzinger, Lukas Weiss, Martin Pichler, Thomas Melchardt, Richard Greil, Alexander Egle
Published 2019-10-01

Non-pegylated Liposomal Doxorubicin as Palliative Chemotherapy in pre-Treated Advanced Pancreatic Cancer: A Retrospective Analysis of Twenty-Eight Patients

by Konstantin Schlick MD, Dominik Kiem MD, Florian Huemer MD, Daniel Neureiter MD, Lukas Weiss MD, Richard Greil MD
Published 2021-09-01

External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients

by Dominik Andreas Barth, Carina Brenner, Jakob Michael Riedl, Felix Prinz, Eva Valentina Klocker, Konstantin Schlick, Peter Kornprat, Karoline Lackner, Herbert Stöger, Michael Stotz, Armin Gerger, Martin Pichler
Published 2020-08-01

Spatial Heterogeneity in Large Resected Diffuse Large B-Cell Lymphoma Bulks Analysed by Massively Parallel Sequencing of Multiple Synchronous Biopsies

by Teresa Magnes, Sandro Wagner, Aaron R. Thorner, Daniel Neureiter, Eckhard Klieser, Gabriel Rinnerthaler, Lukas Weiss, Florian Huemer, Konstantin Schlick, Nadja Zaborsky, Markus Steiner, Richard Greil, Alexander Egle, Thomas Melchardt
Published 2021-02-01

Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients

by Eva Valentina Klocker, Dominik Andreas Barth, Jakob Michael Riedl, Felix Prinz, Joanna Szkandera, Konstantin Schlick, Peter Kornprat, Karoline Lackner, Jörg Lindenmann, Herbert Stöger, Michael Stotz, Armin Gerger, Martin Pichler
Published 2020-05-01

Benefit of second-line therapy for advanced esophageal squamous cell carcinoma: a tri-center propensity score analysis

by Moritz Müller, Florian Posch, Dominik Kiem, Dominik Barth, Lena Horvath, Michael Stotz, Renate Schaberl-Moser, Martin Pichler, Richard Greil, Philipp J. Jost, Andreas Seeber, Arno Amann, Konstantin Schlick, Armin Gerger, Jakob M. Riedl
Published 2021-09-01

Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classificatio...

by Lisa Pleyer, Sonja Burgstaller, Reinhard Stauder, Michael Girschikofsky, Heinz Sill, Konstantin Schlick, Josef Thaler, Britta Halter, Sigrid Machherndl-Spandl, Armin Zebisch, Angelika Pichler, Michael Pfeilstöcker, Eva-Maria Autzinger, Alois Lang, Klaus Geissler, Daniela Voskova, Dietmar Geissler, Wolfgang R. Sperr, Sabine Hojas, Inga M. Rogulj, Johannes Andel, Richard Greil
Published 2016-04-01

Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Aust...

by Lisa Pleyer, Hartmut Döhner, Hervé Dombret, John F. Seymour, Andre C. Schuh, CL Beach, Arlene S. Swern, Sonja Burgstaller, Reinhard Stauder, Michael Girschikofsky, Heinz Sill, Konstantin Schlick, Josef Thaler, Britta Halter, Sigrid Machherndl Spandl, Armin Zebisch, Angelika Pichler, Michael Pfeilstöcker, Eva M. Autzinger, Alois Lang, Klaus Geissler, Daniela Voskova, Wolfgang R. Sperr, Sabine Hojas, Inga M. Rogulj, Johannes Andel, Richard Greil
Published 2017-02-01